US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Vanda Pharmaceuticals

6.75

+0.08001.20%

Post-market: 6.820.0700+1.04%19:52 EST

Volume:1.48M

Turnover:10.08M

Market Cap:398.90M

PE:-4.68

High:6.94

Open:6.71

Low:6.69

Close:6.67

52wk High:7.05

52wk Low:3.81

Shares:59.10M

Float Shares:49.48M

Volume Ratio:0.88

T/O Rate:3.00%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.4426

EPS(LYR):-0.3250

ROE:-16.72%

ROA:-12.15%

PB:0.86

PE(LYR):-20.77

Loading ...

Overview Company News Filings

Vanda Pharmaceuticals Q3 Sales Rise 18% to $56.3 Million

BRIEF-Vanda Pharmaceuticals Q3 EPS USD -0.38

Vanda Pharmaceuticals Q3 Operating Expenses USD 87.542 Million

THOMSON REUTERS

Vanda Pharmaceuticals Inc Outlook 2025 Total REV $210 Mln to $230 Mln

THOMSON REUTERS

Vanda Pharmaceuticals Advances with Promising Social Anxiety Disorder Treatment Study

Vanda Pharmaceuticals Inc expected to post a loss of 45 cents a share - Earnings Preview

Vanda Pharmaceuticals Completes Key Bioequivalence Study for Schizophrenia and Bipolar Disorder Treatment

Jim Cramer Calls Cameco A Good Company, Recommends Buying This Financial Stock

Vanda Pharmaceuticals Reaches Agreement with FDA

Vanda Pharmaceuticals, FDA agree to resolve disputes on Hetlioz and tradipitant

BRIEF-Vanda Pharmaceuticals Says FDA To Expedite Re-review Of Tradipitant By Nov 26

Vanda Pharmaceuticals and FDA Reach Agreement to Pause Litigation, Expedite Reviews of HETLIOZ® and Tradipitant Disputes

Vanda Pharmaceuticals Announces Collaborative Framework for Resolution of Disputes With the U.S. Food and Drug Administration

THOMSON REUTERS

Vanda Pharmaceuticals Inc - to Dismiss Lawsuit Challenging FDA's Clinical Hold on Tradipitant

THOMSON REUTERS

Vanda Pharmaceuticals Inc - FDA to Expedite Re-Review of Hetlioz Snda by Jan 7, 2026

THOMSON REUTERS

High Growth Tech Stocks In The US Market With Promising Potential

Simply Wall St.

Vanda Pharmaceuticals Inc. to Present at Upcoming Cantor Global Healthcare Conference 2025

Vanda Pharmaceuticals Inc. Announces FDA Grant of Orphan Drug Designation for VGT-1849B, a Promising Treatment for Polycythemia Vera

Vanda Pharmaceuticals Announces FDA Granted Orphan Drug Designation for Vgt-1849B, a Novel and Selective Candidate for the Treatment of Polycythemia Vera

THOMSON REUTERS

Vanda Pharmaceuticals Seeks FDA Commissioner's Review of Controversial Approval of Generic Hetlioz® Versions

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/VNDA/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"VNDA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VNDA\",,,,,undefined,":{"symbol":"VNDA","market":"US","secType":"STK","nameCN":"Vanda Pharmaceuticals","latestPrice":6.75,"timestamp":1766178000000,"preClose":6.67,"halted":0,"volume":1484139,"hourTrading":{"tag":"盘后","latestPrice":6.82,"preClose":6.75,"latestTime":"19:52 EST","volume":87027,"amount":587689.1882,"timestamp":1766191939221},"delay":0,"floatShares":49483146,"shares":59096630,"eps":-1.442563,"marketStatus":"Market Closed","change":0.08,"latestTime":"12-19 16:00:00 EST","open":6.71,"high":6.94,"low":6.69,"amount":10080159.293436,"amplitude":0.037481,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.442563,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1766394000000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1144814400000,"exchange":"NASDAQ","adjPreClose":6.67,"preHourTrading":{"tag":"盘前","latestPrice":6.7996,"preClose":6.67,"latestTime":"09:15 EST","volume":2593,"amount":17456.008582,"timestamp":1766153710267},"postHourTrading":{"tag":"盘后","latestPrice":6.82,"preClose":6.75,"latestTime":"19:52 EST","volume":87027,"amount":587689.1882,"timestamp":1766191939221},"volumeRatio":0.8815279226467629,"impliedVol":0.8858,"impliedVolPercentile":0.816},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VNDA\",,,,,undefined,":{"symbol":"VNDA","floatShares":49483146,"roa":"-12.15%","roe":"-16.72%","lyrEps":-0.325026,"volumeRatio":0.8815279226467629,"shares":59096630,"dividePrice":0,"high":6.94,"amplitude":0.037481,"preClose":6.67,"low":6.69,"week52Low":3.8092,"pbRate":"0.86","psRate":"1.88","week52High":7.05,"institutionHeld":0.7314,"latestPrice":6.75,"eps":-1.442563,"divideRate":0,"volume":1484139,"delay":0,"ttmEps":-1.442563,"open":6.71,"prevYearClose":4.79,"prevWeekClose":6.23,"prevMonthClose":5.36,"prevQuarterClose":4.99,"fiveDayClose":6.23,"twentyDayClose":4.84,"sixtyDayClose":4.83},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/VNDA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-10-29","symbol":"VNDA","fiscalQuarterEnding":"2025/09","expectedEps":-0.31,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1761710400000,"reportTimeType":"post","actualEps":-0.38},{"market":"US","date":"2025-07-31","symbol":"VNDA","fiscalQuarterEnding":"2025/06","expectedEps":-0.34,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1753934400000,"reportTimeType":"pre","actualEps":-0.46},{"market":"US","date":"2025-05-07","symbol":"VNDA","fiscalQuarterEnding":"2025/03","expectedEps":-0.55,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1746590400000,"reportTimeType":"post","actualEps":-0.5},{"market":"US","date":"2025-02-13","symbol":"VNDA","fiscalQuarterEnding":"2024/12","expectedEps":-0.14,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1739422800000,"reportTimeType":"post","actualEps":-0.08},{"market":"US","date":"2024-11-06","symbol":"VNDA","fiscalQuarterEnding":"2024/09","expectedEps":-0.17,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1730869200000,"reportTimeType":"post","actualEps":-0.09}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"VNDA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"VNDA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.75,"hold":0.25,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.75,"analysts":4,"updateTime":1762318800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/VNDA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"VNDA","date":"2025-12-19","current":-4.679172,"percent":0.251656,"low":-77.375491,"twenty":-6.411829,"median":23.399568,"eighty":50.47466,"high":127.111916,"avg":22.240343,"sd":35.781232,"marketCap":394174522},"quantilePoints":[{"date":"2020-12-24","current":37.50995,"twenty":-17.144215,"median":7.30609,"eighty":34.52533,"marketCap":726305165},{"date":"2020-12-31","current":37.114514,"twenty":-17.144215,"median":7.332386,"eighty":34.679035,"marketCap":718648333},{"date":"2021-01-08","current":38.978713,"twenty":-17.144215,"median":7.417851,"eighty":34.913039,"marketCap":754744825},{"date":"2021-01-15","current":38.780995,"twenty":-17.144215,"median":7.501124,"eighty":35.145052,"marketCap":750916409},{"date":"2021-01-22","current":40.108531,"twenty":-17.144215,"median":7.631511,"eighty":35.920836,"marketCap":776621486},{"date":"2021-01-29","current":40.503967,"twenty":-17.144215,"median":9.691848,"eighty":36.113637,"marketCap":784278318},{"date":"2021-02-05","current":42.820094,"twenty":-17.144215,"median":9.973445,"eighty":36.379702,"marketCap":829125474},{"date":"2021-02-12","current":42.87234,"twenty":-17.144215,"median":10.161149,"eighty":36.651009,"marketCap":1000511803},{"date":"2021-02-19","current":43.977661,"twenty":-17.144215,"median":10.195815,"eighty":36.786867,"marketCap":1026306677},{"date":"2021-02-26","current":43.860074,"twenty":-17.144215,"median":10.351377,"eighty":36.95069,"marketCap":1023562541},{"date":"2021-03-05","current":42.907616,"twenty":-17.154068,"median":10.647105,"eighty":37.165355,"marketCap":1001335043},{"date":"2021-03-12","current":42.119781,"twenty":-17.154068,"median":11.30316,"eighty":37.398806,"marketCap":982949336},{"date":"2021-03-19","current":41.085013,"twenty":-17.154068,"median":11.789039,"eighty":37.50995,"marketCap":958800943},{"date":"2021-03-26","current":36.38152,"twenty":-17.144215,"median":12.283231,"eighty":37.538196,"marketCap":849035523},{"date":"2021-04-01","current":36.945939,"twenty":-17.144215,"median":12.510069,"eighty":37.538196,"marketCap":862207374},{"date":"2021-04-09","current":38.215882,"twenty":-17.154068,"median":12.594144,"eighty":37.651054,"marketCap":891844037},{"date":"2021-04-16","current":39.203616,"twenty":-17.154068,"median":12.774882,"eighty":37.912898,"marketCap":914894775},{"date":"2021-04-23","current":40.403255,"twenty":-17.154068,"median":12.824175,"eighty":38.140123,"marketCap":942890771},{"date":"2021-04-30","current":39.522336,"twenty":-17.154068,"median":12.914543,"eighty":38.320951,"marketCap":922332752},{"date":"2021-05-07","current":31.503027,"twenty":-17.154068,"median":12.991494,"eighty":38.326403,"marketCap":992376862},{"date":"2021-05-14","current":32.896498,"twenty":-17.154068,"median":13.029375,"eighty":38.326403,"marketCap":1036272591},{"date":"2021-05-21","current":32.614276,"twenty":-17.154068,"median":13.095281,"eighty":38.326403,"marketCap":1027382316},{"date":"2021-05-28","current":31.203166,"twenty":-17.154068,"median":13.194903,"eighty":38.326403,"marketCap":982930945},{"date":"2021-06-04","current":31.92636,"twenty":-17.154068,"median":13.218512,"eighty":38.326403,"marketCap":1005712273},{"date":"2021-06-11","current":33.831358,"twenty":-17.154068,"median":13.226727,"eighty":38.326403,"marketCap":1065721624},{"date":"2021-06-18","current":33.81372,"twenty":-17.154068,"median":13.259589,"eighty":38.326403,"marketCap":1065165982},{"date":"2021-06-25","current":36.653578,"twenty":-17.154068,"median":13.335965,"eighty":38.326403,"marketCap":1154624366},{"date":"2021-07-02","current":36.724134,"twenty":-17.154068,"median":13.357957,"eighty":38.326403,"marketCap":1156846935},{"date":"2021-07-09","current":36.194967,"twenty":-17.154068,"median":13.357957,"eighty":38.326403,"marketCap":1140177671},{"date":"2021-07-16","current":33.390387,"twenty":-17.154068,"median":13.385175,"eighty":38.326403,"marketCap":1051830571},{"date":"2021-07-23","current":34.642747,"twenty":-17.154068,"median":13.434386,"eighty":38.326403,"marketCap":1091281162},{"date":"2021-07-30","current":27.973443,"twenty":-17.154068,"median":13.483596,"eighty":38.326403,"marketCap":907458487},{"date":"2021-08-06","current":27.441759,"twenty":-17.154068,"median":13.631226,"eighty":38.326403,"marketCap":890210656},{"date":"2021-08-13","current":28.24786,"twenty":-17.154068,"median":13.670356,"eighty":38.326403,"marketCap":916360594},{"date":"2021-08-20","current":27.115888,"twenty":-17.154068,"median":13.75522,"eighty":38.326403,"marketCap":879639404},{"date":"2021-08-27","current":29.6371,"twenty":-17.154068,"median":13.826448,"eighty":38.326403,"marketCap":961427508},{"date":"2021-09-03","current":28.71094,"twenty":-17.154068,"median":13.854535,"eighty":38.326403,"marketCap":931382898},{"date":"2021-09-10","current":27.76763,"twenty":-17.154068,"median":13.953851,"eighty":38.326403,"marketCap":900781907},{"date":"2021-09-17","current":29.071113,"twenty":-17.154068,"median":14.053167,"eighty":38.326403,"marketCap":943066913},{"date":"2021-09-24","current":29.602797,"twenty":-17.154068,"median":14.081124,"eighty":38.326403,"marketCap":960314745},{"date":"2021-10-01","current":30.494654,"twenty":-17.154068,"median":14.152482,"eighty":38.326403,"marketCap":989246591},{"date":"2021-10-08","current":31.026339,"twenty":-17.154068,"median":14.270959,"eighty":38.326403,"marketCap":1006494422},{"date":"2021-10-15","current":31.575174,"twenty":-17.154068,"median":14.301456,"eighty":38.326403,"marketCap":1024298636},{"date":"2021-10-22","current":31.386512,"twenty":-17.154068,"median":14.351114,"eighty":38.326403,"marketCap":1018178437},{"date":"2021-10-29","current":29.362682,"twenty":-17.154068,"median":14.4678,"eighty":38.326403,"marketCap":952525401},{"date":"2021-11-05","current":29.12112,"twenty":-17.154068,"median":14.798034,"eighty":38.326403,"marketCap":997806039},{"date":"2021-11-12","current":28.877224,"twenty":-17.154068,"median":14.798034,"eighty":38.326403,"marketCap":989449204},{"date":"2021-11-19","current":27.576448,"twenty":-17.154068,"median":14.798034,"eighty":38.326403,"marketCap":944879420},{"date":"2021-11-26","current":26.909801,"twenty":-17.154068,"median":14.798034,"eighty":38.326403,"marketCap":922037406},{"date":"2021-12-03","current":26.373231,"twenty":-17.154068,"median":14.798034,"eighty":38.326403,"marketCap":903652370},{"date":"2021-12-10","current":25.706583,"twenty":-17.154068,"median":14.798034,"eighty":38.326403,"marketCap":880810356},{"date":"2021-12-17","current":27.153696,"twenty":-17.154068,"median":14.798034,"eighty":38.326403,"marketCap":930394241},{"date":"2021-12-23","current":29.234937,"twenty":-17.154068,"median":14.798034,"eighty":38.326403,"marketCap":1001705895},{"date":"2021-12-31","current":25.511466,"twenty":-17.154068,"median":14.798034,"eighty":38.326403,"marketCap":874124888},{"date":"2022-01-07","current":25.007416,"twenty":-17.144215,"median":14.807432,"eighty":38.3263,"marketCap":856854097},{"date":"2022-01-14","current":24.389547,"twenty":-17.144215,"median":14.956751,"eighty":38.3263,"marketCap":835683450},{"date":"2022-01-21","current":23.072512,"twenty":-17.144215,"median":18.908459,"eighty":38.3263,"marketCap":790556543},{"date":"2022-01-28","current":23.966795,"twenty":-17.144215,"median":23.183837,"eighty":38.3263,"marketCap":821198270},{"date":"2022-02-04","current":19.560417,"twenty":-17.144215,"median":23.576563,"eighty":38.3263,"marketCap":670218126},{"date":"2022-02-11","current":21.983112,"twenty":-17.144215,"median":23.576563,"eighty":38.3263,"marketCap":753229349},{"date":"2022-02-18","current":21.804255,"twenty":-17.144215,"median":23.576563,"eighty":38.3263,"marketCap":747101004},{"date":"2022-02-25","current":18.853723,"twenty":-17.144215,"median":23.576563,"eighty":38.3263,"marketCap":625038638},{"date":"2022-03-04","current":18.280354,"twenty":-17.144215,"median":23.576563,"eighty":38.3263,"marketCap":606030308},{"date":"2022-03-11","current":18.786268,"twenty":-17.144215,"median":23.576563,"eighty":38.3263,"marketCap":622802364},{"date":"2022-03-18","current":20.287146,"twenty":-17.144215,"median":23.576563,"eighty":38.3263,"marketCap":672559465},{"date":"2022-03-25","current":19.32591,"twenty":-17.144215,"median":23.576563,"eighty":38.3263,"marketCap":640692558},{"date":"2022-04-01","current":19.94987,"twenty":-17.144215,"median":23.576563,"eighty":38.3263,"marketCap":661378094},{"date":"2022-04-08","current":19.916143,"twenty":-17.144215,"median":23.576563,"eighty":38.3263,"marketCap":660259957},{"date":"2022-04-14","current":19.157272,"twenty":-17.144215,"median":23.576563,"eighty":38.3263,"marketCap":635101872},{"date":"2022-04-22","current":18.448992,"twenty":-17.144215,"median":23.576563,"eighty":38.3263,"marketCap":611620993},{"date":"2022-04-29","current":16.903143,"twenty":-17.144215,"median":23.576563,"eighty":38.3263,"marketCap":560372983},{"date":"2022-05-06","current":30.007815,"twenty":-17.144215,"median":23.81234,"eighty":38.3263,"marketCap":542301235},{"date":"2022-05-13","current":31.289399,"twenty":-17.144215,"median":23.974925,"eighty":38.3263,"marketCap":565462017},{"date":"2022-05-20","current":31.008076,"twenty":-17.144215,"median":24.499553,"eighty":38.3263,"marketCap":560377943},{"date":"2022-05-27","current":31.94582,"twenty":-17.144215,"median":24.726466,"eighty":38.3263,"marketCap":577324856},{"date":"2022-06-03","current":31.727013,"twenty":-17.144215,"median":24.881125,"eighty":38.3263,"marketCap":573370576},{"date":"2022-06-10","current":30.539204,"twenty":-17.144215,"median":25.073094,"eighty":38.3263,"marketCap":551904486},{"date":"2022-06-17","current":29.914041,"twenty":-17.144215,"median":25.293157,"eighty":38.3263,"marketCap":540606543},{"date":"2022-06-24","current":33.446211,"twenty":-17.154068,"median":25.452351,"eighty":38.326403,"marketCap":604439918},{"date":"2022-07-01","current":34.97786,"twenty":-17.101725,"median":25.564724,"eighty":38.326403,"marketCap":632119877},{"date":"2022-07-08","current":36.759574,"twenty":-17.02494,"median":25.639639,"eighty":38.326403,"marketCap":664319013},{"date":"2022-07-15","current":35.853087,"twenty":-16.800559,"median":25.706583,"eighty":38.326403,"marketCap":647936996},{"date":"2022-07-22","current":34.29018,"twenty":-16.579017,"median":26.014214,"eighty":38.326403,"marketCap":619692140},{"date":"2022-07-29","current":33.696276,"twenty":-15.600428,"median":26.267051,"eighty":38.326403,"marketCap":608959095},{"date":"2022-08-05","current":54.282127,"twenty":3.791287,"median":26.340711,"eighty":38.356987,"marketCap":596723424},{"date":"2022-08-12","current":53.561796,"twenty":4.32242,"median":26.426246,"eighty":38.538084,"marketCap":588804819},{"date":"2022-08-19","current":53.253082,"twenty":4.487703,"median":26.576076,"eighty":38.789104,"marketCap":585411131},{"date":"2022-08-26","current":52.73856,"twenty":4.580888,"median":26.909801,"eighty":38.878336,"marketCap":579754985},{"date":"2022-09-02","current":53.407439,"twenty":4.668262,"median":27.104917,"eighty":38.971271,"marketCap":587107975},{"date":"2022-09-09","current":52.944369,"twenty":4.722768,"median":27.300033,"eighty":39.099148,"marketCap":582017443},{"date":"2022-09-16","current":51.246444,"twenty":4.761973,"median":27.45891,"eighty":39.345148,"marketCap":563352161},{"date":"2022-09-23","current":49.754329,"twenty":4.810183,"median":27.630421,"eighty":39.443307,"marketCap":546949337},{"date":"2022-09-30","current":50.834826,"twenty":4.836812,"median":27.76763,"eighty":39.543622,"marketCap":558827244},{"date":"2022-10-07","current":50.783374,"twenty":4.921115,"median":27.924545,"eighty":39.763436,"marketCap":558261629},{"date":"2022-10-14","current":50.47466,"twenty":4.941755,"median":28.024896,"eighty":39.984463,"marketCap":554867942},{"date":"2022-10-21","current":53.355987,"twenty":4.983255,"median":28.178057,"eighty":40.08767,"marketCap":586542360},{"date":"2022-10-28","current":54.590841,"twenty":5.012956,"median":28.291875,"eighty":40.302998,"marketCap":600117111},{"date":"2022-11-04","current":91.788849,"twenty":5.062961,"median":28.448949,"eighty":40.563626,"marketCap":595893205},{"date":"2022-11-11","current":93.27072,"twenty":5.093819,"median":28.590882,"eighty":40.972842,"marketCap":605513513},{"date":"2022-11-18","current":93.096382,"twenty":5.117101,"median":28.71094,"eighty":41.160269,"marketCap":604381712},{"date":"2022-11-25","current":90.91716,"twenty":5.138736,"median":28.748609,"eighty":41.266594,"marketCap":590234200},{"date":"2022-12-02","current":95.101267,"twenty":5.157046,"median":28.985358,"eighty":41.937708,"marketCap":617397423},{"date":"2022-12-09","current":91.614511,"twenty":5.176833,"median":29.071113,"eighty":42.119781,"marketCap":594761404},{"date":"2022-12-16","current":61.454072,"twenty":5.208554,"median":29.234937,"eighty":42.368145,"marketCap":398959838},{"date":"2022-12-23","current":59.885032,"twenty":5.239077,"median":29.511352,"eighty":43.046766,"marketCap":388773629},{"date":"2022-12-30","current":64.417815,"twenty":5.255617,"median":29.543872,"eighty":43.602452,"marketCap":418200454},{"date":"2023-01-06","current":64.679322,"twenty":5.277282,"median":29.6371,"eighty":43.9356,"marketCap":419898156},{"date":"2023-01-13","current":66.858544,"twenty":5.292197,"median":30.070331,"eighty":44.079494,"marketCap":434045668},{"date":"2023-01-20","current":65.725348,"twenty":5.315176,"median":30.184129,"eighty":48.044423,"marketCap":426688961},{"date":"2023-01-27","current":66.684206,"twenty":5.339308,"median":30.476687,"eighty":49.929267,"marketCap":432913867},{"date":"2023-02-03","current":66.684206,"twenty":5.359134,"median":30.528529,"eighty":50.515822,"marketCap":432913867},{"date":"2023-02-10","current":65.789461,"twenty":5.371292,"median":30.60172,"eighty":50.989183,"marketCap":412828869},{"date":"2023-02-17","current":63.889078,"twenty":5.395729,"median":30.726752,"eighty":51.812419,"marketCap":400903963},{"date":"2023-02-24","current":58.549906,"twenty":5.423851,"median":30.872928,"eighty":52.172585,"marketCap":367400658},{"date":"2023-03-03","current":57.644961,"twenty":5.475409,"median":30.940583,"eighty":52.779722,"marketCap":361722131},{"date":"2023-03-10","current":56.106556,"twenty":5.507294,"median":31.026339,"eighty":52.96495,"marketCap":352068636},{"date":"2023-03-17","current":59.002378,"twenty":5.539642,"median":31.129245,"eighty":53.139887,"marketCap":370239921},{"date":"2023-03-24","current":61.08375,"twenty":5.565634,"median":31.256083,"eighty":53.407439,"marketCap":383300532},{"date":"2023-03-31","current":61.445728,"twenty":5.591919,"median":31.406014,"eighty":53.726443,"marketCap":385571942},{"date":"2023-04-06","current":61.08375,"twenty":5.638122,"median":31.503027,"eighty":53.89109,"marketCap":383300532},{"date":"2023-04-14","current":62.803145,"twenty":5.715788,"median":31.776429,"eighty":54.282127,"marketCap":394089732},{"date":"2023-04-21","current":56.016061,"twenty":5.800167,"median":31.94582,"eighty":55.571109,"marketCap":351500784},{"date":"2023-04-28","current":56.757062,"twenty":5.889576,"median":32.228692,"eighty":56.160852,"marketCap":356150561},{"date":"2023-05-05","current":24.731543,"twenty":6.039467,"median":32.415379,"eighty":56.342329,"marketCap":394641234},{"date":"2023-05-12","current":22.319588,"twenty":6.525956,"median":32.447324,"eighty":56.360184,"marketCap":356153661},{"date":"2023-05-19","current":21.995594,"twenty":6.590821,"median":32.447324,"eighty":56.360184,"marketCap":350983689},{"date":"2023-05-26","current":21.563602,"twenty":6.773144,"median":32.447324,"eighty":56.360184,"marketCap":344090392},{"date":"2023-06-01","current":21.419604,"twenty":6.793305,"median":32.447324,"eighty":56.360184,"marketCap":341792627},{"date":"2023-06-09","current":23.399568,"twenty":7.081692,"median":32.455526,"eighty":56.453844,"marketCap":373386903},{"date":"2023-06-16","current":22.823578,"twenty":7.191261,"median":32.455526,"eighty":56.453844,"marketCap":364195841},{"date":"2023-06-23","current":23.147572,"twenty":7.30346,"median":32.473165,"eighty":56.605453,"marketCap":369365813},{"date":"2023-06-30","current":23.975557,"twenty":7.332386,"median":32.537703,"eighty":56.681257,"marketCap":382577965},{"date":"2023-07-07","current":23.651563,"twenty":7.360874,"median":32.602241,"eighty":56.757062,"marketCap":377407993},{"date":"2023-07-14","current":21.707599,"twenty":7.488413,"median":32.608258,"eighty":56.771752,"marketCap":346388158},{"date":"2023-07-21","current":23.039574,"twenty":7.560291,"median":32.653799,"eighty":56.801131,"marketCap":367642489},{"date":"2023-07-28","current":24.900298,"twenty":17.199629,"median":32.693323,"eighty":56.815821,"marketCap":371089137},{"date":"2023-08-04","current":21.763998,"twenty":17.370024,"median":32.473165,"eighty":56.272572,"marketCap":324348859},{"date":"2023-08-11","current":23.230366,"twenty":17.370024,"median":32.261499,"eighty":55.997962,"marketCap":346202151},{"date":"2023-08-18","current":22.535771,"twenty":17.370024,"median":31.94582,"eighty":54.55997,"marketCap":335850591},{"date":"2023-08-25","current":22.034118,"twenty":17.370024,"median":31.802888,"eighty":54.096899,"marketCap":328374465},{"date":"2023-09-01","current":20.027509,"twenty":17.370024,"median":31.503027,"eighty":53.757314,"marketCap":298469960},{"date":"2023-09-08","current":17.635012,"twenty":17.239057,"median":31.414833,"eighty":53.448601,"marketCap":262814589},{"date":"2023-09-15","current":18.329608,"twenty":17.226892,"median":31.272741,"eighty":53.253082,"marketCap":273166149},{"date":"2023-09-22","current":17.210537,"twenty":16.940417,"median":31.137821,"eighty":52.995821,"marketCap":256488636},{"date":"2023-09-29","current":16.824651,"twenty":16.932962,"median":31.041743,"eighty":52.851754,"marketCap":250737770},{"date":"2023-10-06","current":17.210537,"twenty":16.732038,"median":30.974885,"eighty":52.316651,"marketCap":256488636},{"date":"2023-10-13","current":16.747473,"twenty":16.670296,"median":30.914301,"eighty":52.06968,"marketCap":249587597},{"date":"2023-10-20","current":16.631708,"twenty":16.608555,"median":30.837677,"eighty":51.246444,"marketCap":247862337},{"date":"2023-10-27","current":16.940417,"twenty":16.539095,"median":30.726752,"eighty":50.824536,"marketCap":252463030},{"date":"2023-11-02","current":16.863239,"twenty":16.11462,"median":30.60172,"eighty":50.454079,"marketCap":251312857},{"date":"2023-11-10","current":16.521509,"twenty":16.014289,"median":30.520167,"eighty":49.754329,"marketCap":194458156},{"date":"2023-11-17","current":16.521509,"twenty":16.014289,"median":30.468519,"eighty":44.73022,"marketCap":194458156},{"date":"2023-11-24","current":17.401352,"twenty":16.014289,"median":30.189254,"eighty":43.977661,"marketCap":204813916},{"date":"2023-12-01","current":18.183436,"twenty":16.014289,"median":30.039073,"eighty":43.860074,"marketCap":214019036},{"date":"2023-12-08","current":19.405441,"twenty":16.11462,"median":29.6371,"eighty":43.094886,"marketCap":228402036},{"date":"2023-12-15","current":18.818878,"twenty":16.014289,"median":29.535742,"eighty":42.820094,"marketCap":221498196},{"date":"2023-12-21","current":18.574477,"twenty":15.983418,"median":29.511352,"eighty":42.218766,"marketCap":218621596},{"date":"2023-12-27","current":19.796482,"twenty":15.967983,"median":29.362682,"eighty":42.119781,"marketCap":233004595},{"date":"2024-01-05","current":20.676326,"twenty":14.280594,"median":29.131142,"eighty":41.900534,"marketCap":243360355},{"date":"2024-01-12","current":19.16104,"twenty":14.280594,"median":29.033964,"eighty":41.266594,"marketCap":225525436},{"date":"2024-01-19","current":18.036795,"twenty":12.624076,"median":28.933904,"eighty":41.111092,"marketCap":212293076},{"date":"2024-01-26","current":18.525597,"twenty":14.280594,"median":28.73835,"eighty":40.950245,"marketCap":218046276},{"date":"2024-02-02","current":18.232316,"twenty":14.280594,"median":28.702365,"eighty":40.554867,"marketCap":214594356},{"date":"2024-02-09","current":93.335042,"twenty":14.280594,"median":28.628365,"eighty":40.422302,"marketCap":234177620},{"date":"2024-02-16","current":100.214775,"twenty":14.280594,"median":28.628365,"eighty":40.499585,"marketCap":251438870},{"date":"2024-02-23","current":99.297477,"twenty":14.280594,"median":28.628365,"eighty":40.499585,"marketCap":249137370},{"date":"2024-03-01","current":102.508019,"twenty":15.937112,"median":28.665848,"eighty":40.503967,"marketCap":257192620},{"date":"2024-03-08","current":87.601931,"twenty":15.937112,"median":28.665848,"eighty":40.589905,"marketCap":219793246},{"date":"2024-03-15","current":87.143283,"twenty":15.937112,"median":28.665848,"eighty":41.040631,"marketCap":218642496},{"date":"2024-03-22","current":89.665851,"twenty":15.937112,"median":28.665848,"eighty":41.2026,"marketCap":224971621},{"date":"2024-03-28","current":89.207202,"twenty":15.937112,"median":28.665848,"eighty":41.767019,"marketCap":223820871},{"date":"2024-04-05","current":112.827619,"twenty":14.280594,"median":28.628365,"eighty":42.195037,"marketCap":283084495},{"date":"2024-04-12","current":98.150855,"twenty":14.280594,"median":28.628365,"eighty":43.126328,"marketCap":246260495},{"date":"2024-04-19","current":113.974241,"twenty":14.280594,"median":28.628365,"eighty":43.954144,"marketCap":285961370},{"date":"2024-04-26","current":102.737344,"twenty":15.937112,"median":28.665848,"eighty":44.091139,"marketCap":257767995},{"date":"2024-05-03","current":108.555431,"twenty":15.937112,"median":28.665848,"eighty":49.033997,"marketCap":272365577},{"date":"2024-05-10","current":-59.638647,"twenty":7.636989,"median":28.55658,"eighty":49.908686,"marketCap":291573347},{"date":"2024-05-17","current":-66.423883,"twenty":7.498932,"median":28.385069,"eighty":49.908686,"marketCap":324746363},{"date":"2024-05-24","current":-58.448255,"twenty":7.393745,"median":28.282163,"eighty":49.908686,"marketCap":285753520},{"date":"2024-05-31","current":-59.638647,"twenty":7.332386,"median":28.178057,"eighty":49.908686,"marketCap":291573347},{"date":"2024-06-07","current":-74.637589,"twenty":7.30609,"median":28.024896,"eighty":49.908686,"marketCap":364903171},{"date":"2024-06-14","current":-77.375491,"twenty":7.19915,"median":27.948994,"eighty":49.918976,"marketCap":378288774},{"date":"2024-06-21","current":-71.125932,"twenty":7.118945,"median":27.784781,"eighty":49.929267,"marketCap":347734681},{"date":"2024-06-28","current":-69.161785,"twenty":7.043123,"median":27.699025,"eighty":49.960138,"marketCap":338131966},{"date":"2024-07-05","current":-63.80502,"twenty":6.810836,"median":27.600837,"eighty":49.960138,"marketCap":311942743},{"date":"2024-07-12","current":-69.042746,"twenty":6.637716,"median":27.435935,"eighty":49.960138,"marketCap":337549983},{"date":"2024-07-15","current":-70.471216,"twenty":6.635525,"median":27.384481,"eighty":49.960138,"marketCap":344533776},{"date":"2024-08-02","current":-30.086439,"twenty":6.577672,"median":27.104917,"eighty":50.433498,"marketCap":328754517},{"date":"2024-08-09","current":-28.326062,"twenty":6.484758,"median":26.909801,"eighty":50.433498,"marketCap":309518880},{"date":"2024-08-16","current":-27.579236,"twenty":5.966713,"median":26.576076,"eighty":50.433498,"marketCap":301358307},{"date":"2024-08-23","current":-28.272717,"twenty":5.88344,"median":26.426246,"eighty":50.433498,"marketCap":308935982},{"date":"2024-08-30","current":-27.845959,"twenty":5.768902,"median":26.340711,"eighty":50.433498,"marketCap":304272797},{"date":"2024-09-06","current":-27.099133,"twenty":5.715788,"median":26.332602,"eighty":50.433498,"marketCap":296112224},{"date":"2024-09-13","current":-26.61903,"twenty":5.655719,"median":26.295145,"eighty":50.433498,"marketCap":290866141},{"date":"2024-09-20","current":-24.805309,"twenty":5.58998,"median":26.295145,"eighty":50.433498,"marketCap":271047607},{"date":"2024-09-27","current":-25.285411,"twenty":5.563517,"median":26.295145,"eighty":50.433498,"marketCap":276293689},{"date":"2024-10-04","current":-24.005137,"twenty":5.528419,"median":26.295145,"eighty":50.433498,"marketCap":262304136},{"date":"2024-10-11","current":-23.525035,"twenty":5.491943,"median":26.295145,"eighty":50.433498,"marketCap":257058053},{"date":"2024-10-18","current":-25.258739,"twenty":5.461327,"median":26.295145,"eighty":50.433498,"marketCap":276002240},{"date":"2024-10-25","current":-24.111827,"twenty":5.418839,"median":26.295145,"eighty":50.433498,"marketCap":263469932},{"date":"2024-10-31","current":-24.325206,"twenty":5.391868,"median":26.014214,"eighty":50.433498,"marketCap":265801524},{"date":"2024-11-08","current":-17.855433,"twenty":5.367499,"median":26.015518,"eighty":50.454079,"marketCap":292614836},{"date":"2024-11-15","current":-18.145688,"twenty":5.359134,"median":26.015518,"eighty":50.454079,"marketCap":297371534},{"date":"2024-11-22","current":-17.576411,"twenty":5.328527,"median":26.015518,"eighty":50.454079,"marketCap":288042231},{"date":"2024-11-29","current":-18.323587,"twenty":5.313305,"median":26.015518,"eighty":50.454079,"marketCap":300286941},{"date":"2024-12-06","current":-17.007135,"twenty":5.288291,"median":26.015518,"eighty":50.454079,"marketCap":278712928},{"date":"2024-12-13","current":-16.437858,"twenty":5.274959,"median":26.015518,"eighty":50.454079,"marketCap":269383625},{"date":"2024-12-20","current":-16.473438,"twenty":5.247835,"median":26.015518,"eighty":50.454079,"marketCap":269966706},{"date":"2024-12-27","current":-17.113874,"twenty":5.219777,"median":26.015518,"eighty":50.454079,"marketCap":280462172},{"date":"2025-01-03","current":-17.149454,"twenty":5.200137,"median":26.015518,"eighty":50.454079,"marketCap":281045254},{"date":"2025-01-10","current":-16.544598,"twenty":5.172047,"median":26.048037,"eighty":50.47466,"marketCap":271132869},{"date":"2025-01-17","current":-15.797422,"twenty":5.151955,"median":26.048037,"eighty":50.47466,"marketCap":258888159},{"date":"2025-01-24","current":-15.726263,"twenty":5.141617,"median":26.048037,"eighty":50.47466,"marketCap":257721996},{"date":"2025-01-31","current":-16.295539,"twenty":5.116334,"median":26.048037,"eighty":50.47466,"marketCap":267051299},{"date":"2025-02-07","current":-16.686917,"twenty":5.087903,"median":26.048037,"eighty":50.47466,"marketCap":273465195},{"date":"2025-02-14","current":-14.499909,"twenty":5.060621,"median":26.048037,"eighty":50.47466,"marketCap":274048276},{"date":"2025-02-21","current":-13.853917,"twenty":5.016797,"median":26.048037,"eighty":50.47466,"marketCap":261839037},{"date":"2025-02-28","current":-14.501873,"twenty":4.989699,"median":26.048037,"eighty":50.47466,"marketCap":274085406},{"date":"2025-03-07","current":-15.149829,"twenty":4.942936,"median":26.113076,"eighty":50.47466,"marketCap":286331776},{"date":"2025-03-14","current":-15.180684,"twenty":4.942346,"median":26.113076,"eighty":50.47466,"marketCap":286914936},{"date":"2025-03-21","current":-15.180684,"twenty":4.942346,"median":26.113076,"eighty":50.47466,"marketCap":286914936},{"date":"2025-03-28","current":-14.193323,"twenty":4.942346,"median":26.113076,"eighty":50.47466,"marketCap":268253802},{"date":"2025-04-04","current":-13.483657,"twenty":4.939984,"median":26.113076,"eighty":50.47466,"marketCap":254841112},{"date":"2025-04-11","current":-12.58886,"twenty":4.887176,"median":26.048037,"eighty":50.47466,"marketCap":237929459},{"date":"2025-04-17","current":-13.483657,"twenty":4.834368,"median":26.048037,"eighty":50.47466,"marketCap":254841112},{"date":"2025-04-25","current":-13.298526,"twenty":4.763966,"median":26.113076,"eighty":50.47466,"marketCap":251342149},{"date":"2025-05-02","current":-13.844808,"twenty":4.709103,"median":26.113076,"eighty":50.47466,"marketCap":261666880},{"date":"2025-05-09","current":-5.620625,"twenty":4.634656,"median":26.113076,"eighty":50.47466,"marketCap":248701404},{"date":"2025-05-16","current":-5.234418,"twenty":4.508876,"median":26.113076,"eighty":50.47466,"marketCap":231612514},{"date":"2025-05-23","current":-5.647311,"twenty":-5.223763,"median":26.113076,"eighty":50.47466,"marketCap":249882203},{"date":"2025-05-30","current":-5.847098,"twenty":-5.402239,"median":26.113076,"eighty":50.47466,"marketCap":258722375},{"date":"2025-06-06","current":-5.847098,"twenty":-5.740545,"median":26.113076,"eighty":50.47466,"marketCap":258722375},{"date":"2025-06-13","current":-6.166757,"twenty":-5.793821,"median":26.113076,"eighty":50.47466,"marketCap":272866651},{"date":"2025-06-20","current":-6.033565,"twenty":-5.913693,"median":26.178114,"eighty":50.47466,"marketCap":266973203},{"date":"2025-06-27","current":-6.41982,"twenty":-6.006927,"median":26.178114,"eighty":50.47466,"marketCap":284064203},{"date":"2025-07-03","current":-6.619607,"twenty":-6.105489,"median":26.178114,"eighty":50.47466,"marketCap":292904375},{"date":"2025-07-11","current":-6.646245,"twenty":-6.217369,"median":26.178114,"eighty":50.47466,"marketCap":294083065},{"date":"2025-07-18","current":-6.473097,"twenty":-6.382527,"median":26.178114,"eighty":50.47466,"marketCap":286421582},{"date":"2025-07-25","current":-6.379863,"twenty":-6.411829,"median":26.178114,"eighty":50.47466,"marketCap":282296168},{"date":"2025-08-01","current":-3.760546,"twenty":-6.411829,"median":26.178114,"eighty":50.47466,"marketCap":251719693},{"date":"2025-08-08","current":-3.707581,"twenty":-6.411829,"median":26.178114,"eighty":50.47466,"marketCap":248174346},{"date":"2025-08-15","current":-3.910615,"twenty":-6.411829,"median":26.178114,"eighty":50.47466,"marketCap":261764845},{"date":"2025-08-22","current":-3.981236,"twenty":-6.411829,"median":26.178114,"eighty":50.47466,"marketCap":266491976},{"date":"2025-08-29","current":-4.14896,"twenty":-6.411829,"median":26.178114,"eighty":50.47466,"marketCap":277718911},{"date":"2025-09-05","current":-4.095994,"twenty":-6.414492,"median":26.252526,"eighty":50.47466,"marketCap":274173563},{"date":"2025-09-12","current":-4.060684,"twenty":-6.411829,"median":26.178114,"eighty":50.47466,"marketCap":271809998},{"date":"2025-09-19","current":-3.990063,"twenty":-6.411829,"median":26.178114,"eighty":50.47466,"marketCap":267082867},{"date":"2025-09-26","current":-4.263718,"twenty":-6.411829,"median":26.178114,"eighty":50.47466,"marketCap":285400497},{"date":"2025-10-03","current":-4.555028,"twenty":-6.411829,"median":26.178114,"eighty":50.47466,"marketCap":304899910},{"date":"2025-10-10","current":-4.811028,"twenty":-6.411829,"median":26.178114,"eighty":50.47466,"marketCap":322035758},{"date":"2025-10-17","current":-4.652131,"twenty":-6.411829,"median":26.178114,"eighty":50.47466,"marketCap":311399715},{"date":"2025-10-24","current":-4.846338,"twenty":-6.411829,"median":26.178114,"eighty":50.47466,"marketCap":324399323},{"date":"2025-10-31","current":-3.031687,"twenty":-6.411829,"median":25.934219,"eighty":50.47466,"marketCap":255265041},{"date":"2025-11-07","current":-3.09524,"twenty":-6.411829,"median":25.511466,"eighty":50.47466,"marketCap":260616138},{"date":"2025-11-14","current":-3.04611,"twenty":-6.411829,"median":24.900298,"eighty":50.47466,"marketCap":256479374},{"date":"2025-11-21","current":-3.397044,"twenty":-6.411829,"median":24.407549,"eighty":50.47466,"marketCap":286027689},{"date":"2025-11-28","current":-3.762015,"twenty":-6.411829,"median":23.966795,"eighty":50.47466,"marketCap":316757936},{"date":"2025-12-05","current":-3.649716,"twenty":-6.411829,"median":23.820458,"eighty":50.47466,"marketCap":307302476},{"date":"2025-12-12","current":-4.632332,"twenty":-6.411829,"median":23.543565,"eighty":50.47466,"marketCap":390037758},{"date":"2025-12-19","current":-4.681463,"twenty":-6.411829,"median":23.399568,"eighty":50.47466,"marketCap":394174522}],"updateTime":1766338466151},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"VNDA\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2579138265","title":"Vanda Pharmaceuticals Q3 Sales Rise 18% to $56.3 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2579138265","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579138265?lang=en_us&edition=fundamental","pubTime":"2025-10-30 04:01","pubTimestamp":1761768109,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vanda Pharmaceuticals Inc. published the original content used to generate this news brief via PR Newswire  on October 29, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251029:nNDL982DMM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VNDA"],"gpt_icon":0},{"id":"2579384071","title":"BRIEF-Vanda Pharmaceuticals Q3 EPS USD -0.38","url":"https://stock-news.laohu8.com/highlight/detail?id=2579384071","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579384071?lang=en_us&edition=fundamental","pubTime":"2025-10-30 04:01","pubTimestamp":1761768105,"startTime":"0","endTime":"0","summary":"BRIEF-Vanda Pharmaceuticals Q3 EPS USD -0.38\n\n\nOct 29 (Reuters) - Vanda Pharmaceuticals Q3 operating income USD -31.284 million.\n\nQ3 net income USD -22.586 million\nQ3 basic EPS USD -0.38\nQ3 operating expenses USD 87.542 million","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251029:nPLXB2F341:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VNDA"],"gpt_icon":0},{"id":"2579483138","title":"Vanda Pharmaceuticals Q3 Operating Expenses USD 87.542 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2579483138","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579483138?lang=en_us&edition=fundamental","pubTime":"2025-10-30 04:01","pubTimestamp":1761768060,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251029:nPLXB2F341:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","VNDA"],"gpt_icon":0},{"id":"2579139317","title":"Vanda Pharmaceuticals Inc Outlook 2025 Total REV $210 Mln to $230 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2579139317","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579139317?lang=en_us&edition=fundamental","pubTime":"2025-10-30 04:01","pubTimestamp":1761768060,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251029:nPLXB2F341:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VNDA","BK4139"],"gpt_icon":0},{"id":"2579964228","title":"Vanda Pharmaceuticals Advances with Promising Social Anxiety Disorder Treatment Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2579964228","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579964228?lang=en_us&edition=fundamental","pubTime":"2025-10-29 00:31","pubTimestamp":1761669062,"startTime":"0","endTime":"0","summary":"Vanda Pharmaceuticals (($VNDA)) announced an update on their ongoing clinical study. Study Overview: Vanda Pharmaceuticals is conducting a Phase II...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vanda-pharmaceuticals-advances-with-promising-social-anxiety-disorder-treatment-study?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vanda-pharmaceuticals-advances-with-promising-social-anxiety-disorder-treatment-study?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VNDA","BK4139"],"gpt_icon":0},{"id":"2578967184","title":"Vanda Pharmaceuticals Inc  expected to post a loss of 45 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2578967184","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578967184?lang=en_us&edition=fundamental","pubTime":"2025-10-28 05:31","pubTimestamp":1761600679,"startTime":"0","endTime":"0","summary":"Vanda Pharmaceuticals Inc  expected to post a loss of45cents a share - Earnings Preview Vanda Pharmaceuticals Inc VNDA.OQ VNDA.O is expected to  show a rise in quarterly revenue when it reports  resul","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251027:nL8N3W821F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VNDA","BK4139"],"gpt_icon":0},{"id":"2578626283","title":"Vanda Pharmaceuticals Completes Key Bioequivalence Study for Schizophrenia and Bipolar Disorder Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2578626283","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578626283?lang=en_us&edition=fundamental","pubTime":"2025-10-28 00:32","pubTimestamp":1761582722,"startTime":"0","endTime":"0","summary":"Vanda Pharmaceuticals (($VNDA)) announced an update on their ongoing clinical study. Study Overview: The study titled ‘Crossover Bioequivalence Stu...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vanda-pharmaceuticals-completes-key-bioequivalence-study-for-schizophrenia-and-bipolar-disorder-treatment?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vanda-pharmaceuticals-completes-key-bioequivalence-study-for-schizophrenia-and-bipolar-disorder-treatment?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","VNDA"],"gpt_icon":0},{"id":"2578895649","title":"Jim Cramer Calls Cameco A Good Company, Recommends Buying This Financial Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2578895649","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578895649?lang=en_us&edition=fundamental","pubTime":"2025-10-27 20:05","pubTimestamp":1761566700,"startTime":"0","endTime":"0","summary":"On CNBC's \"Mad Money Lightning Round,\" Jim Cramer discussed Apollo Global, National Fuel Gas, Main Street Capital and Vanda Pharmaceuticals.","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/10/27/Jim-Cramer_2.jpeg?optimize=medium&dpr=2&auto=webp&width=260","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/10/27/Jim-Cramer_2.jpeg?optimize=medium&dpr=2&auto=webp&width=260"],"rights":{"source":"benzinga_hot_news","url":"https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/10/48429905/jim-cramer-calls-cameco-a-good-company-recommends-buying-this-financial-stock","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/10/48429905/jim-cramer-calls-cameco-a-good-company-recommends-buying-this-financial-stock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_hot_news","symbols":["LU1668664300.SGD","IE00B19Z3581.USD","LU1791807156.HKD","IE00B3S45H60.SGD","BK4591","LU0787776722.HKD","NFG","CCJ","LU0823414551.USD","LU2506951792.HKD","LU2294711713.HKD","IE0002270589.USD","LU1323610961.USD","APO","BK4585","IE00B19Z3B42.SGD","BK4139","BK4184","LU0106831901.USD","BK4197","IE00B775SV38.USD","BK4588","LU2249611893.SGD","MAIN","LU0006061336.USD","BK4156","VNDA","LU0823414478.USD","LU0683600562.USD","BK4606","LU2357125470.USD","BK4135"],"gpt_icon":0},{"id":"2572563802","title":"Vanda Pharmaceuticals Reaches Agreement with FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2572563802","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572563802?lang=en_us&edition=fundamental","pubTime":"2025-10-02 05:27","pubTimestamp":1759354076,"startTime":"0","endTime":"0","summary":"Vanda ( ($VNDA) ) has issued an update. On October 1, 2025, Vanda Pharmaceuticals Inc. announced a collaborative framework with the U.S. Food and D...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vanda-pharmaceuticals-reaches-agreement-with-fda?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vanda-pharmaceuticals-reaches-agreement-with-fda?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VNDA","BK4139"],"gpt_icon":0},{"id":"2572432568","title":"Vanda Pharmaceuticals, FDA agree to resolve disputes on Hetlioz and tradipitant","url":"https://stock-news.laohu8.com/highlight/detail?id=2572432568","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572432568?lang=en_us&edition=fundamental","pubTime":"2025-10-02 05:10","pubTimestamp":1759353008,"startTime":"0","endTime":"0","summary":"Vanda Pharmaceuticals (VNDA) announced that it has agreed on a collaborative framework with the FDA for the resolution of certain disputes regardin...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/vanda-pharmaceuticals-fda-agree-to-resolve-disputes-on-hetlioz-and-tradipitant-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/vanda-pharmaceuticals-fda-agree-to-resolve-disputes-on-hetlioz-and-tradipitant-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VNDA","BK4139"],"gpt_icon":0},{"id":"2572568363","title":"BRIEF-Vanda Pharmaceuticals Says FDA To Expedite Re-review Of Tradipitant By Nov 26","url":"https://stock-news.laohu8.com/highlight/detail?id=2572568363","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572568363?lang=en_us&edition=fundamental","pubTime":"2025-10-02 05:09","pubTimestamp":1759352949,"startTime":"0","endTime":"0","summary":"BRIEF-Vanda Pharmaceuticals Says FDA To Expedite Re-review Of Tradipitant By Nov 26Oct 1 (Reuters) - Vanda Pharmaceuticals Inc VNDA.O:VANDA PHARMACEUTICALS ANNOUNCES COLLABORATIVE FRAMEWORK FOR RESOLU","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251001:nTUA8LLD4B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VNDA"],"gpt_icon":0},{"id":"2572500155","title":"Vanda Pharmaceuticals and FDA Reach Agreement to Pause Litigation, Expedite Reviews of HETLIOZ® and Tradipitant Disputes","url":"https://stock-news.laohu8.com/highlight/detail?id=2572500155","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572500155?lang=en_us&edition=fundamental","pubTime":"2025-10-02 05:03","pubTimestamp":1759352585,"startTime":"0","endTime":"0","summary":"Vanda Pharmaceuticals Inc. has reached a collaborative agreement with the U.S. Food and Drug Administration to resolve several ongoing disputes involving its drugs Hetlioz and tradipitant. As part of the agreement, Vanda will dismiss lawsuits related to the FDA's clinical hold on tradipitant for motion sickness and regarding the dissemination of information about Hetlioz for jet lag disorder. The FDA will expedite its review of the clinical hold on tradipitant, aiming for a decision by November 26, 2025, and will continue reviewing the new drug application for this indication, with a target action date of December 30, 2025. Additionally, the FDA will conduct an expedited re-review of Vanda's supplemental application for Hetlioz in jet lag disorder by January 7, 2026, considering alternative indications focused on sleep-related symptoms. Both parties have also agreed to temporarily pause related administrative and legal proceedings during these reviews.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251001:nNDL1W6wMF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VNDA"],"gpt_icon":0},{"id":"2572550065","title":"Vanda Pharmaceuticals Announces Collaborative Framework for Resolution of Disputes With the U.S. Food and Drug Administration","url":"https://stock-news.laohu8.com/highlight/detail?id=2572550065","media":"THOMSON REUTERS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572550065?lang=en_us&edition=fundamental","pubTime":"2025-10-02 05:02","pubTimestamp":1759352571,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251001:nTUA8LLD4B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","VNDA"],"gpt_icon":0},{"id":"2572550016","title":"Vanda Pharmaceuticals Inc - to Dismiss Lawsuit Challenging FDA's Clinical Hold on Tradipitant","url":"https://stock-news.laohu8.com/highlight/detail?id=2572550016","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572550016?lang=en_us&edition=fundamental","pubTime":"2025-10-02 05:02","pubTimestamp":1759352571,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251001:nTUA8LLD4B:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","VNDA"],"gpt_icon":0},{"id":"2572155001","title":"Vanda Pharmaceuticals Inc - FDA to Expedite Re-Review of Hetlioz Snda by Jan 7, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2572155001","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572155001?lang=en_us&edition=fundamental","pubTime":"2025-10-02 05:02","pubTimestamp":1759352571,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251001:nTUA8LLD4B:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VNDA","BK4139"],"gpt_icon":0},{"id":"2571308123","title":"High Growth Tech Stocks In The US Market With Promising Potential","url":"https://stock-news.laohu8.com/highlight/detail?id=2571308123","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571308123?lang=en_us&edition=fundamental","pubTime":"2025-09-29 19:08","pubTimestamp":1759144086,"startTime":"0","endTime":"0","summary":"As the U.S. stock market navigates a period of volatility with major indexes snapping a three-day losing streak yet posting weekly losses, high growth tech stocks continue to capture investor interest due to their potential for innovation and expansion in an evolving economic landscape. In such a dynamic environment, identifying companies that demonstrate strong technological advancements and adaptability can be crucial for investors seeking opportunities in the high-growth tech sector.","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-vnda/vanda-pharmaceuticals/news/high-growth-tech-stocks-in-the-us-market-with-promising-pote-2","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-vnda/vanda-pharmaceuticals/news/high-growth-tech-stocks-in-the-us-market-with-promising-pote-2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4535","TASK","ALDX","BK4226","BK4106","BK4139","VNDA","BK4539"],"gpt_icon":0},{"id":"2563061043","title":"Vanda Pharmaceuticals Inc. to Present at Upcoming Cantor Global Healthcare Conference 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2563061043","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2563061043?lang=en_us&edition=fundamental","pubTime":"2025-08-29 05:24","pubTimestamp":1756416244,"startTime":"0","endTime":"0","summary":"Vanda Pharmaceuticals Inc. announced its participation in the H.C. Wainwright Annual Global Investment Conference in New York City on Tuesday, September 9, 2025. The company is scheduled to give a corporate presentation at 8:30 a.m. Eastern Time.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vanda Pharmaceuticals Inc. published the original content used to generate this news brief via PR Newswire  on August 28, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250828:nNDL4nQ6PS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VNDA","BK4139"],"gpt_icon":0},{"id":"2562303524","title":"Vanda Pharmaceuticals Inc. Announces FDA Grant of Orphan Drug Designation for VGT-1849B, a Promising Treatment for Polycythemia Vera","url":"https://stock-news.laohu8.com/highlight/detail?id=2562303524","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562303524?lang=en_us&edition=fundamental","pubTime":"2025-08-28 19:01","pubTimestamp":1756378874,"startTime":"0","endTime":"0","summary":"Vanda Pharmaceuticals Inc. Announces FDA Grant of Orphan Drug Designation for VGT-1849B, a Promising Treatment for Polycythemia Vera. Vanda Pharmaceuticals Inc. has announced that the U.S. Food and Drug Administration  has granted Orphan Drug Designation for their novel therapeutic candidate, VGT-1849B, intended for the treatment of polycythemia vera . This designation aims to facilitate the development of this selective peptide nucleic acid-based JAK2 inhibitor, which targets the JAK2 V617F mutation prevalent in over 95% of PV patients. The Orphan Drug Designation provides benefits to drug developers working on treatments for rare medical conditions. VGT-1849B is designed to offer targeted efficacy with an improved safety profile and convenient infrequent dosing, potentially enhancing the quality of life for patients with PV.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely inform","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250828:nNDL5PmBYB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VNDA","BK4139"],"gpt_icon":0},{"id":"2562356740","title":"Vanda Pharmaceuticals Announces FDA Granted Orphan Drug Designation for Vgt-1849B, a Novel and Selective Candidate for the Treatment of Polycythemia Vera","url":"https://stock-news.laohu8.com/highlight/detail?id=2562356740","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562356740?lang=en_us&edition=fundamental","pubTime":"2025-08-28 19:00","pubTimestamp":1756378809,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250828:nTUA6KXTNS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VNDA","BK4139"],"gpt_icon":0},{"id":"2561416739","title":"Vanda Pharmaceuticals Seeks FDA Commissioner's Review of Controversial Approval of Generic Hetlioz® Versions","url":"https://stock-news.laohu8.com/highlight/detail?id=2561416739","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561416739?lang=en_us&edition=fundamental","pubTime":"2025-08-22 04:40","pubTimestamp":1755808847,"startTime":"0","endTime":"0","summary":"Vanda Pharmaceuticals Inc. has requested a review by FDA Commissioner Martin Makary regarding a recent decision by the FDA's Center for Drug Evaluation and Research  to uphold the approval of two generic versions of Vanda's drug, Hetlioz. This request follows a decision made by outgoing CDER director Jacqueline Corrigan-Curay, supporting the approval of these generics despite Vanda's concerns about significant flaws in the studies and data presented. Vanda argues that the approval process demonstrated bias towards generic drugs, potentially endangering public safety. The Office of the Commissioner is expected to take two months to decide whether to review the merits of this decision.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vanda","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250821:nNDLbWn1ls:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VNDA","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":3,"totalSize":72,"code":"91000000","status":"200"}]}}